ProCE Banner Activity

CCO Official Conference Coverage of HIVR4P 2024

Video

On-demand webcast of expert faculty presentation on the key studies from HIVR4P 2024 and how these new data will impact your clinical practice.

Released: November 04, 2024

Expiration: November 03, 2025

Share

Faculty

Beatriz Grinsztejn

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Raphael J. Landovitz

Raphael J. Landovitz, MD, MSc

Professor of Medicine
Interim Chief, Division of Infectious Diseases
David Geffen School of Medicine at UCLA
Director, UCLA Center for Clinical AIDS Research & Education
Co-Director, UCLA Center for HIV Identification, Prevention, and Treatment Services
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Beatriz Grinsztejn, MD, PhD: consultant/advisor: Gilead, Merck, ViiV.

Raphael J. Landovitz, MD, MSc

Professor of Medicine
Interim Chief, Division of Infectious Diseases
David Geffen School of Medicine at UCLA
Director, UCLA Center for Clinical AIDS Research & Education
Co-Director, UCLA Center for HIV Identification, Prevention, and Treatment Services
Los Angeles, California

Raphael J. Landovitz, MD, MSc: consultant/advisor/speaker: Merck, RedQueen Therapeutics, ViiV.